(Health-NewsWire.Net, October 06, 2017 ) Though there has been substantial development in science and technology to combat cancer, it continues to threaten lives across the globe. Colorectal cancer, the third most common type of cancer is fast becoming a horrible reality for many.
View Full Report @ http://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/
Colorectal cancer is a consequence of unrestrained cell growth that occurs in the appendix, colon, and the rectum region. Some of the generally seen symptoms of colorectal cancer are blood in the stool, weight loss, fatigue, and irregular bowel movements. Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/request-sample
The growth of the Global Colorectal Cancer Market is mainly driven by factors such as rise in pipeline colorectal cancer screening tests, aging population, increasing awareness, and government policies to provide better care for Colorectal Cancer. However, high costs of screening tests and poor availability of proper cancer care in the emerging regions are hindering the growth of the market.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/inquire
The Global Colorectal Cancer market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.
The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Rest of the World. North America accounted for the largest share in the global Colorectal Cancer market followed by Asia-Pacific and Europe. However, The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as increasing participation of several private & public establishments to organize awareness programs on Colorectal Cancer.
The major companies dominating the Colorectal Cancer market are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|